Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2026-03-12 @ 5:04 AM
Study NCT ID:
NCT00717366
Status:
COMPLETED
Last Update Posted:
2017-09-08
First Post:
2008-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-16
First Submit QC Date:
None
Study First Post Date:
2008-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-29
Results First Submit QC Date:
None
Results First Post Date:
2017-09-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-08
Last Update Post Date:
2017-09-08
Last Update Post Date Type:
ACTUAL